SARS CoV 2 News and Research

RSS

What was SARS-CoV-2 antibody seroprevalence in Italian blood donors?

Researchers evaluated titers and types of severe acute respiratory syndrome coronavirus 2 antibodies in voluntary blood donors.

1 Jun 2023

Study: 1 in 6 unvaccinated individuals still experiencing covid-19 effects up to two years after infection

Around 1 in 6 unvaccinated individuals say they are still experiencing health effects of covid-19 up to two years after infection, finds a study from Switzerland published by The BMJ today.

31 May 2023

Spike in childhood human metapneumovirus infections in Western Australia linked to reduced COVID-19 measures

Researchers investigated the prevalence of human metapneumovirus through 2020 considering the implementation of NPIs due to the COVID-19 pandemic.

31 May 2023

Long-term consequences of COVID-19 in patients with inflammatory rheumatic diseases

Studies on the long-term consequences of COVID-19 (long-COVID) in patients with inflammatory rheumatic diseases (iRD) are scarce.

31 May 2023

COVID-19's shifting impact: the changing relationship between infections and severe outcomes

Exploring the dynamics of SARS-CoV-2 infection hospitalization and fatality ratios in England.

31 May 2023

The immunopathology of post-acute sequelae of SARS-CoV-2 infection: highlighting the knowledge gaps

The immunopathology of post-acute sequelae of SARS-CoV-2 infection (PASC).

31 May 2023

Experimental decoy provides long-term protection from SARS-Cov-2 infection

An experimental "decoy" provided long-term protection from infection by the pandemic virus in mice, a new study finds.

30 May 2023

New method may help identify the essential ingredients for making an effective HIV vaccine

Since it was identified in 1984 as the cause of Acquired Immune Deficiency Syndrome (AIDS), the human immunodeficiency virus (HIV) has infected more than 80 million people and been responsible for some 40 million deaths worldwide, according to the World Health Organization (WHO).

30 May 2023

What is the subsequent risk of mental disorders among individuals with SARS-CoV-2 infection, and are the associations specific for COVID-19?

Researchers estimated psychiatric disorders and psychotropic medication usage risks among SARS-CoV-2-infected.

30 May 2023

Risk of long COVID in the United Kingdom and Hong Kong cohorts

Study evaluates the risk of post-acute sequelae of COVID-19 in the United Kingdom (UK) and Hong Kong (HK).

30 May 2023

Novel technology enhances potency and breadth of vaccine-induced responses through antigen presentation

Novel EABR technology enhances potency and breadth of vaccine-induced responses through antigen presentation.

30 May 2023

Defining long-COVID using self-reported symptoms

Researchers developed a symptom-based criteria to identify post-acute sequelae of SARS-CoV-2 infection.

30 May 2023

Study maps immune responses produced by COVID-19 vaccination in First Nations population

Published in Nature Immunology and Nature Briefing, the research is the first of its kind to decisively map immune responses produced by a COVID-19 vaccination in any First Nations populations.

29 May 2023

MHRA authorizes new COVID-19 vaccine from SK Chemicals

SKYCovion, the COVID-19 vaccine developed by SK Chemicals, has today been authorized by the Medicines and Healthcare products Regulatory Agency (MHRA).

26 May 2023

Large study uncovers new details about long COVID

Initial findings from a study of nearly 10,000 Americans, many of whom had COVID-19, have uncovered new details about long COVID, the post-infection set of conditions that can affect nearly every tissue and organ in the body.

26 May 2023

Top-Down Proteomics: Bridging the Genotype-to-Phenotype Gap

In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to this year's recipient of the Pittsburgh Analytical Chemistry Award, Neil Kelleher, about his work in top-down proteinomics.

From Pittcon 26 May 2023

The potential clinical benefit of the Multabody platform as a therapeutic for SARS-CoV-2

The potential clinical benefit of the Multabody platform as a therapeutic for SARS-CoV-2.

26 May 2023

Associations between exposure to air pollution and severe COVID-19

Researchers explored associations between prolonged exposure to air pollution and severe coronavirus disease 2019.

26 May 2023

T-cell-inducing mRNA COVID-19 vaccine improves effectiveness

Researchers develop a lipid nanoparticle-formulated mRNA-based antigen encoding three SARS-CoV-2 peptides derived from non-structural proteins.

25 May 2023

RECOVER study: An important step toward defining long COVID

A study led by the National Institutes of Health's RECOVER Initiative and supported by NYU Langone Health, home to the effort's Clinical Science Core (CSC), provides an expanded working definition of long COVID.

25 May 2023

SARS CoV 2 News and Research

What was SARS-CoV-2 antibody seroprevalence in Italian blood donors?

Study: 1 in 6 unvaccinated individuals still experiencing covid-19 effects up to two years after infection

Spike in childhood human metapneumovirus infections in Western Australia linked to reduced COVID-19 measures

Long-term consequences of COVID-19 in patients with inflammatory rheumatic diseases

COVID-19's shifting impact: the changing relationship between infections and severe outcomes

The immunopathology of post-acute sequelae of SARS-CoV-2 infection: highlighting the knowledge gaps

Experimental decoy provides long-term protection from SARS-Cov-2 infection

New method may help identify the essential ingredients for making an effective HIV vaccine

What is the subsequent risk of mental disorders among individuals with SARS-CoV-2 infection, and are the associations specific for COVID-19?

Risk of long COVID in the United Kingdom and Hong Kong cohorts

Novel technology enhances potency and breadth of vaccine-induced responses through antigen presentation

Defining long-COVID using self-reported symptoms

Study maps immune responses produced by COVID-19 vaccination in First Nations population

MHRA authorizes new COVID-19 vaccine from SK Chemicals

Large study uncovers new details about long COVID

Top-Down Proteomics: Bridging the Genotype-to-Phenotype Gap

The potential clinical benefit of the Multabody platform as a therapeutic for SARS-CoV-2

Associations between exposure to air pollution and severe COVID-19

T-cell-inducing mRNA COVID-19 vaccine improves effectiveness

RECOVER study: An important step toward defining long COVID

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News